Yüklüyor......
New targets for therapy in breast cancer: Small molecule tyrosine kinase inhibitors
Over the past several years many advances have been made in our understanding of critical pathways involved in carcinogenesis and tumor growth. These advances have led to the investigation of small molecule inhibitors of the ErbB family of receptor tyrosine kinases across a broad spectrum of maligna...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2004
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC549180/ https://ncbi.nlm.nih.gov/pubmed/15318926 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr919 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|